Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05138458
Title A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL (IMAGINE)
Acronym IMAGINE
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Myeloid Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.